Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

dezamizumab

A fully humanized monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Upon intravenous administration, dezamizumab binds to SAP in amyloid deposits, thereby activating compliment and triggering the rapid clearance of amyloid by macrophage-derived multinucleated giant cells. SAP is a universal component of amyloid deposits and contributes to the pathogenesis of amyloidosis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-SAP mAb
anti-SAP monoclonal antibody
Code name:GSK 2398852
GSK-2398852
GSK2398852
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search